Palumbo Wealth Management »

Black Diamond Therapeutics shares owned by Palumbo Wealth Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Palumbo Wealth Management from 13F filings

Historical chart of Palumbo Wealth Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Palumbo Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Palumbo Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $52k 10k 5.07

More positions owned by Palumbo Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Invesco Db Commdy Indx Trck Unit (DBC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Apple (AAPL)
Waste Management (WM)
Ishares Tr Tips Bd Etf (TIP)
Microsoft Corporation (MSFT)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Sprott Physical Gold Tr Unit (PHYS)
Costco Wholesale Corporation (COST)
Visa Com Cl A (V)

View all positions for Palumbo Wealth Management

Top funds holding Black Diamond Therapeutics

Bellevue Group
NEA Management Company
RA Capital Management
Artal Group
Vanguard Group
Tang Capital Management
Jpmorgan Chase & Co
Kennedy Capital Management
Blue Owl Capital Holdings
Ikarian Capital
Boxer Capital
Susquehanna International
Two Sigma Investments
Connor, Clark & Lunn Investment Management
Newtyn Management

View all funds holding Black Diamond Therapeutics